Figure 5
From: Rapamycin attenuates pathological hypertrophy caused by an absence of trabecular formation

Schematic diagram illustrating that trabeculae-deficient erbb2 mutants undergo TOR-dependent pathological hypertrophy.
From: Rapamycin attenuates pathological hypertrophy caused by an absence of trabecular formation

Schematic diagram illustrating that trabeculae-deficient erbb2 mutants undergo TOR-dependent pathological hypertrophy.